Tecan and InSphero have developed a novel solution for analyzing 3D cell cultures based on the Infinite® M200 PRO and InSphero’s 3D InSight™ microtissue technology. This solution is designed to facilitate the use of 3D cell culture formats in drug screening applications, helping to reduce the cost of early phase drug development.
